...Office of Women’s Health, and the Office of Laboratory Safety will be supervised by the Office of the Chief Scientist. Steve...

...perform.” Elaine Johanson, who is acting director of the Office of Health Informatics at FDA’s Office of the Chief Scientist...

...a strategic decision by FDA’s Office of Regulatory Science and Innovation, which sits within the Office of the Chief Scientist...

...for a cut of future fund profits FutuRx Accelerator Jan. 2014 The Technological Incubators Program, Office of the Chief Scientist...

...with the Israeli government, Johnson & Johnson (NYSE:JNJ) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). Israel's Office of the Chief Scientist...
...million in non-dilutive financing to each FutuRx company. "After companies graduate from the incubator, Israel's Office of the Chief Scientist...

...policy and director of the FDA's Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist...

...pharmaceutical component, including 70% where drug candidates are the sole focus. (A) Public-private partnership with Office of the Chief Scientist...

...Scientific Research; The National Centre for Research and Development; National Science Centre; Project Management Julich; Office of the Chief Scientist...

...Innovation, the pharma's early stage collaborations unit. FutuRx is the result of efforts by Israel's Office of the Chief Scientist...

...company can remain in the incubator for up to three years. The pharma said Israel's Office of the Chief Scientist...